2-amino-9-[17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one

C20H26N12O11P2 — CID 137420719

IUPAC2-amino-9-[17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one
SMILESNc1nc2c(ncn2C2OC3COP(=O)(O)NC4C(COP(=O)(O)NC3C2O)OC(n2cnc3c(N)ncnc32)C4O)c(=O)[nH]1
InChIInChI=1S/C20H26N12O11P2/c21-14-10-15(24-3-23-14)31(4-25-10)18-12(33)8-6(42-18)1-40-45(38,39)30-9-7(2-41-44(36,37)29-8)43-19(13(9)34)32-5-26-11-16(32)27-20(22)28-17(11)35/h3-9,12-13,18-19,33-34H,1-2H2,(H2,21,23,24)(H2,29,36,37)(H2,30,38,39)(H3,22,27,28,35)
InChIKeyPJUHRFXLHLFLFK-UHFFFAOYSA-N
MW672.45 g/mol
LogP-3.20
Rot. Bonds2

About 2-amino-9-[17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one

2-amino-9-[17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one (PubChem CID 137420719) has the molecular formula C20H26N12O11P2 and a molecular weight of 672.45 g/mol. Its IUPAC name is 2-amino-9-[17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one.

Molecular Properties

Compound Name2-amino-9-[17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one
PubChem CID137420719
Molecular FormulaC20H26N12O11P2
Molecular Weight672.45 g/mol
Exact Mass672.13
IUPAC Name2-amino-9-[17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one
SMILESNc1nc2c(ncn2C2OC3COP(=O)(O)NC4C(COP(=O)(O)NC3C2O)OC(n2cnc3c(N)ncnc32)C4O)c(=O)[nH]1
InChIInChI=1S/C20H26N12O11P2/c21-14-10-15(24-3-23-14)31(4-25-10)18-12(33)8-6(42-18)1-40-45(38,39)30-9-7(2-41-44(36,37)29-8)43-19(13(9)34)32-5-26-11-16(32)27-20(22)28-17(11)35/h3-9,12-13,18-19,33-34H,1-2H2,(H2,21,23,24)(H2,29,36,37)(H2,30,38,39)(H3,22,27,28,35)
InChIKeyPJUHRFXLHLFLFK-UHFFFAOYSA-N
XLogP-3.20
TPSA335.25 Ų
H-Bond Donors9
H-Bond Acceptors18
Rotatable Bonds2
Heavy Atoms45
Complexity

Lipinski Rule of Five

3 violations

RuleValue
MW ≤ 500672.45
LogP ≤ 5-3.20
H-Bond Donors ≤ 59
H-Bond Acceptors ≤ 1018

Computed Properties (RDKit)

Structural Alerts{'alert_name': 'phosphor', 'substructure': 'N/A'}

Analyze 2-amino-9-[17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one with MolForge

Explore ADMET properties, 3D molecular structure, drug-likeness score, and discover similar compounds using our AI-powered platform.

Launch Full Analysis

Related Compounds

Frequently Asked Questions

What is the IUPAC name of 2-amino-9-[17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one?
The IUPAC name of 2-amino-9-[17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one (CID 137420719) is 2-amino-9-[17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one.
What is the SMILES notation for 2-amino-9-[17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one?
The canonical SMILES for 2-amino-9-[17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one is Nc1nc2c(ncn2C2OC3COP(=O)(O)NC4C(COP(=O)(O)NC3C2O)OC(n2cnc3c(N)ncnc32)C4O)c(=O)[nH]1.
What is the InChIKey of 2-amino-9-[17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one?
The InChIKey is PJUHRFXLHLFLFK-UHFFFAOYSA-N. The full InChI is InChI=1S/C20H26N12O11P2/c21-14-10-15(24-3-23-14)31(4-25-10)18-12(33)8-6(42-18)1-40-45(38,39)30-9-7(2-41-44(36,37)29-8)43-19(13(9)34)32-5-26-11-16(32)27-20(22)28-17(11)35/h3-9,12-13,18-19,33-34H,1-2H2,(H2,21,23,24)(H2,29,36,37)(H2,30,38,39)(H3,22,27,28,35).
What are the key properties of 2-amino-9-[17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one?
2-amino-9-[17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one has a molecular weight of 672.45 g/mol, XLogP of -3.20, 2 rotatable bonds, 9 hydrogen bond donors, and 18 hydrogen bond acceptors.
Where does this data come from?
All data for 2-amino-9-[17-(6-aminopurin-9-yl)-3,9,12,18-tetrahydroxy-3,12-dioxo-4,7,13,16-tetraoxa-2,11-diaza-3λ5,12λ5-diphosphatricyclo[13.3.0.06,10]octadecan-8-yl]-1H-purin-6-one is sourced from PubChem (CID 137420719), the world's largest open chemistry database maintained by the National Library of Medicine (NIH).